Is Olympus Corp - ADR (OLYMY) Stock a Good Investment?
Learn more about Olympus Corp - ADR's (OLYMY) stock grades for Momentum and determine whether this Advanced Medical Equipment & Technology stock meets your investment needs.Jack Gilleland
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | OLYMY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $11,933.2 | $380.3 | 80% |
|
| Shares Out (Mil) | 6.8 | 41.2 | 17% |
|
| Institutional Ownership | 50.0% | 84.0% | 29% |
|
| Float (Mil) | 1,040.0 | 35.2 | 91% |
|
| Beta | 0.27 | 0.85 | 15% |
|
| Avg Daily Volume (000s) | 77 | 341 | 33% |
|
| Price Change (52-week) |
(16.2%) | 59.6% | 38% |
|
| Growth | OLYMY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (0.8%) | 11.8% | 16% |
|
| Net Income (5yr) | 29.7% | (5.6%) | 85% |
|
| EPS (5yr) | 33.4% | 10.6% | 84 |
|
| Dividends (5yr) | 11.7% | 0.0% | 60% |
|
| Cash Flow (5yr) | (27.4%) | (16.0%) | 23% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | OLYMY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $6,783 | $127 | 78% |
|
| Net Income (TTM) (Mil) | $580 | ($9) | 80% |
|
| EPS (TTM) | $0.534 | ($0.300) | 53% |
|
| Operating Cash Flow (TTM) (Mil) | $903 | ($1) | 79% |
|
| Net Cash Flow (TTM) (Mil) | ($53) | $2 | 21% |
|
| Long-Term Debt (Q1) (Mil) | $1,568 | $25 | 71% |
|
| Enterprise Value (Q1) (Mil) | $13,149 | $400 | 78% |
|
| Valuation | OLYMY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.62 | na |
|
| P/E | na | 26.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | OLYMY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 66.2% | 59.1% | 78% |
|
| Net Margin | 8.5% | (4.5%) | 58% |
|
| ROA | 6.0% | (11.0%) | 75% |
|
| ROE | 11.9% | (8.5%) | 62% |
|
| Liabilities to Assets | 50.4% | 45.9% | 43% |
|
| F-Score | na | 4 | na |
|
Olympus Corporation did not pass any screens on 11/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors